Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

GSK invests £1.25mm in hearing loss spin-out Autifony, out-licenses candidates

Executive Summary

For a 25.4% stake, GlaxoSmithKline PLC’s Glaxo Group Ltd. is investing £1.25mm ($2.06mm) into its hearing loss spin-out Autifony Therapeutics Ltd., which is issuing the Big Pharma 850k A ordinary shares.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Reverse Licensing
    • R+D and Marketing-Licensing
    • Includes Equity

Related Companies

Advertisement
UsernamePublicRestriction

Register